Retrospective observational study of the use of artemether-lumefantrine in the treatment of malaria in Japan
The Research Group on Chemotherapy of Tropical Diseases, Japan, introduced artemether –lumefantrine (AL) in late 2002, mainly for treating uncomplicated Plasmodium falciparum malaria. Because AL was on the market in Japan in March 2017, the effectiveness and safety of AL were analyzed to help medical personnel use AL optimally. (Source: Travel Medicine and Infectious Disease)
Source: Travel Medicine and Infectious Disease - February 15, 2018 Category: Infectious Diseases Authors: Fukumi Nakamura-Uchiyama, Yuichi Katanami, Tadashi Kikuchi, Saho Takaya, Satoshi Kutsuna, Taiichiro Kobayashi, Yasutaka Mizuno, Tetsuo Hasegawa, Michiko Koga, Yukihiro Yoshimura, Chihiro Hasegawa, Yasuyuki Kato, Mikio Kimura, Haruhiko Maruyama, for the Re Source Type: research

When travel is a challenge: Travel medicine and the ‘dis-abled’ traveller
Travellers with recognised disabilities or the dis-ability to function as required during a trip have been overlooked in the travel medicine literature. This paper provides a starting point for further discussion and research into this neglected traveller population. In contrast, tourism research has explored travel with a disability for some time in order to understand the travellers' needs and to improve services accordingly. The contemporary bio-psycho-social understanding of disability serves as the framework for exploring motivations to travel as well as barriers, such as inter and intrapersonal, economic, structural ...
Source: Travel Medicine and Infectious Disease - February 15, 2018 Category: Infectious Diseases Authors: Irmgard Bauer Source Type: research

Retrospective observational study of the use of artemether-lumefantrine in the treatment of malaria in Japan
The Research Group on Chemotherapy of Tropical Diseases, Japan, introduced artemether –lumefantrine (AL) in late 2002, mainly for treating uncomplicated Plasmodium falciparum malaria. Because AL was on the market in Japan in March 2017, the effectiveness and safety of AL were analyzed to help medical personnel use AL optimally. (Source: Travel Medicine and Infectious Disease)
Source: Travel Medicine and Infectious Disease - February 15, 2018 Category: Infectious Diseases Authors: Fukumi Nakamura-Uchiyama, Yuichi Katanami, Tadashi Kikuchi, Saho Takaya, Satoshi Kutsuna, Taiichiro Kobayashi, Yasutaka Mizuno, Tetsuo Hasegawa, Michiko Koga, Yukihiro Yoshimura, Chihiro Hasegawa, Yasuyuki Kato, Mikio Kimura, Haruhiko Maruyama, for the Re Source Type: research

Travel medicine related to the El Camino pilgrimage
I read with interest a recent paper on pilgrimage travel [1] and I believe that pre-travel advice for pilgrims is becoming more and more important. Obviously, the Hajj pilgrimage is relevant due to the huge number of participants. However, I would like to draw your attention to another lesser known pilgrimage: the Saint James Way (the “El Camino”). This medieval pilgrim's way is more than 800 km long and the number of participants is continuously growing. In 2016, some 278,000 pilgrims accomplished this (in travel medicine terms) long distance hike [2]. (Source: Travel Medicine and Infectious Disease)
Source: Travel Medicine and Infectious Disease - February 5, 2018 Category: Infectious Diseases Authors: Peter P. Felkai Source Type: research

Community-acquired urinary tract infections due to extended-spectrum β -lactamase-producing organisms in United Arab Emirates
The epidemiology of extended-spectrum β-lactamase (ESBL)-producing bacteria is fast evolving with increasing global trend towards community-acquired infections. Limited information available about ESBLs therapy outcomes and control strategies, especially in the Middle Eastern countries. (Source: Travel Medicine and Infectious Disease)
Source: Travel Medicine and Infectious Disease - February 4, 2018 Category: Infectious Diseases Authors: Nihar Ranjan Dash, Mohammad T. Albataineh, Nawar Alhourani, Ammar Mohammad Khoudeir, Mohammed Ghanim, Mohammad Wasim, Ibrahim Mahmoud Source Type: research

Travellers' diarrhoea: Impact of TD definition and control group design on study results
Travellers' diarrhoea (TD) is a common health problem among visitors to the (sub)tropics. Much research deals with aetiology, prevention, and post-infection sequalae, yet the data may not allow comparisons due to incompatible definitions of TD and No TD control groups. (Source: Travel Medicine and Infectious Disease)
Source: Travel Medicine and Infectious Disease - February 3, 2018 Category: Infectious Diseases Authors: Tinja L ääveri, Sari H. Pakkanen, Juha Kirveskari, Anu Kantele Source Type: research

Fasciola hepatica – Convoluted life forms and names
The fluke Fasciola hepatica has a complex life cycle, involving ruminants, particularly sheep and cattle (as final hosts that shed eggs), miracidia (emerge from eggs in freshwater and penetrate amphibious snail tissue), cercariae (that emerge from snails), and metacercariae (form that attachs to water plants). Nearly as convoluted are the names for this trematode and its life forms. (Source: Travel Medicine and Infectious Disease)
Source: Travel Medicine and Infectious Disease - February 3, 2018 Category: Infectious Diseases Authors: Dieter St ürchler Source Type: research

Travellers' diarrhoea: Impact of TD definition and control group design on study results
Travellers' diarrhoea (TD) is a common health problem among visitors to the (sub)tropics. Much research deals with aetiology, prevention, and post-infection sequalae, yet the data may not allow comparisons due to incompatible definitions of TD and No TD control groups. (Source: Travel Medicine and Infectious Disease)
Source: Travel Medicine and Infectious Disease - February 3, 2018 Category: Infectious Diseases Authors: Tinja L ääveri, Sari H. Pakkanen, Juha Kirveskari, Anu Kantele Source Type: research

Fasciola hepatica – convoluted life forms and names
The fluke Fasciola hepatica has a complex life cycle, involving ruminants, particularly sheep and cattle (as final hosts that shed eggs), miracidia (emerge from eggs in freshwater and penetrate amphibious snail tissue), cercariae (that emerge from snails), and metacercariae (form that attachs to water plants). Nearly as convoluted are the names for this trematode and its life forms. (Source: Travel Medicine and Infectious Disease)
Source: Travel Medicine and Infectious Disease - February 3, 2018 Category: Infectious Diseases Authors: Dieter St ürchler Source Type: research

Fever of unknown origin due to Legionnaires' disease: A diagnostic challenge
A 66-year-old Thai woman presented with a 3-week history of recurrent fever, malaise, anorexia and weight loss which followed a self-limited influenza-like illness. She had been previously healthy, except for hypothyroidism, hypertension and dyslipidemia, until 2 weeks after returning from Turkey. (Source: Travel Medicine and Infectious Disease)
Source: Travel Medicine and Infectious Disease - February 2, 2018 Category: Infectious Diseases Authors: Thatchai Kampitak Source Type: research

Spontaneous Mycobacterium bolletti skin abscesses — An underrecognized zoonosis from raw bovine milk
Cutaneous mycobacterial infections are a source of substantial burden of disease in both developed and developing countries. Leprosy, cutaneous tuberculosis, and Buruli ulcer are the leading cutaneous mycobacterial diseases. However, over the last few decades, there is an increasing recognition of rapidly growing mycobacterial infections as important causes of chronic skin and soft tissue infections. Although most cutaneous infections are trauma or surgery related; traveling may pose an additional risk to develop this infection. (Source: Travel Medicine and Infectious Disease)
Source: Travel Medicine and Infectious Disease - February 1, 2018 Category: Infectious Diseases Authors: Andr és F. Henao-Martínez, Nancy Olague, Carlos Franco-Paredes Source Type: research

Spontaneous Mycobacterium bolletti skin abscesses —an underrecognized zoonosis from raw bovine milk
Cutaneous mycobacterial infections are a source of substantial burden of disease in both developed and developing countries. Leprosy, cutaneous tuberculosis, and Buruli ulcer are the leading cutaneous mycobacterial diseases. However, over the last few decades, there is an increasing recognition of rapidly growing mycobacterial infections as important causes of chronic skin and soft tissue infections. Although most cutaneous infections are trauma or surgery related; traveling may pose an additional risk to develop this infection. (Source: Travel Medicine and Infectious Disease)
Source: Travel Medicine and Infectious Disease - February 1, 2018 Category: Infectious Diseases Authors: Andr és F. Henao-Martínez, Nancy Olague, Carlos Franco-Paredes Source Type: research